• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化部分脾栓塞术后门静脉血栓形成:抗凝治疗的疗效和长期随访。

Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.

机构信息

Department of Radiology, the Third Affiliated Hospital, and Interventional Radiology Institute, Sun Yat-sen University, 600 Tianhe Road, Guangzhou, Guangdong, 510630, China.

出版信息

J Vasc Interv Radiol. 2013 Dec;24(12):1808-16. doi: 10.1016/j.jvir.2013.08.018. Epub 2013 Oct 4.

DOI:10.1016/j.jvir.2013.08.018
PMID:24099787
Abstract

PURPOSE

To investigate the treatment and long-term outcome of portal vein thrombosis (PVT) after partial splenic embolization (PSE).

MATERIALS AND METHODS

From January 2006 to December 2011, 145 patients with hypersplenism caused by cirrhotic portal hypertension underwent PSE. In 11 cases, PVT was detected 13-42 days after PSE. Among the 11 patients, 5 underwent anticoagulant therapy because of clinical symptoms, and 6 did not receive anticoagulation because they were symptom-free (4 patients) or experienced variceal bleeding (2 patients). The long-term follow-up data from these 11 patients were analyzed retrospectively.

RESULTS

The 11 patients with PVT had a mean splenic infarction ratio of 71.5%. The mean duration of follow-up was 37.6 months. During the follow-up period, none of the 5 patients who underwent anticoagulation developed variceal hemorrhage despite presenting with large esophagogastric varices. Four of the five patients achieved complete resolution of thrombosis, and one did not develop thrombus progression. However, among the 6 patients who did not undergo anticoagulation, 2 developed esophagogastric variceal hemorrhage secondary to thrombus progression, 3 developed cavernous transformation of the portal vein and variceal progression, and 1 had partial calcification of the thrombus. Two patients who had variceal bleeding or rebleeding underwent a transjugular intrahepatic portosystemic shunt. Complete recanalization of the portal vein was achieved after the procedures.

CONCLUSIONS

PVT is a severe, potentially fatal complication of PSE. Early detection of PVT and prompt anticoagulation are effective to avoid serious consequences of PVT.

摘要

目的

探讨部分性脾栓塞(PSE)后门静脉血栓形成(PVT)的治疗和长期转归。

材料与方法

2006 年 1 月至 2011 年 12 月,145 例肝硬化门静脉高压症所致脾功能亢进患者行 PSE 治疗。PSE 后 13-42 天发现 11 例 PVT。11 例患者中,5 例因临床症状接受抗凝治疗,6 例无症状(4 例)或因食管胃静脉曲张出血(2 例)未接受抗凝治疗。回顾性分析这 11 例患者的长期随访资料。

结果

11 例 PVT 患者脾梗死比例平均为 71.5%。平均随访时间为 37.6 个月。随访期间,5 例抗凝治疗患者尽管存在大的食管胃静脉曲张,但均未发生静脉曲张出血。其中 4 例血栓完全溶解,1 例未发生血栓进展。然而,6 例未抗凝治疗患者中,2 例因血栓进展发生食管胃静脉曲张出血,3 例发生门静脉海绵样变性和静脉曲张进展,1 例血栓部分钙化。2 例有静脉曲张出血或再出血的患者行经颈静脉肝内门体分流术。术后门静脉完全再通。

结论

PVT 是 PSE 的一种严重的、潜在致命的并发症。早期发现 PVT 并及时抗凝治疗可避免 PVT 的严重后果。

相似文献

1
Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.肝硬化部分脾栓塞术后门静脉血栓形成:抗凝治疗的疗效和长期随访。
J Vasc Interv Radiol. 2013 Dec;24(12):1808-16. doi: 10.1016/j.jvir.2013.08.018. Epub 2013 Oct 4.
2
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.前瞻性评估抗凝和经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成。
Liver Int. 2012 Jul;32(6):919-27. doi: 10.1111/j.1478-3231.2012.02785.x. Epub 2012 Mar 21.
3
Comparison of percutaneous transhepatic variceal embolization (PTVE) followed by partial splenic embolization versus PTVE alone for the treatment of acute esophagogastric variceal massive hemorrhage.经皮经肝门静脉栓塞术(PTVE)联合部分脾栓塞术与单纯PTVE治疗急性食管胃静脉曲张大出血的比较
J Vasc Interv Radiol. 2014 Dec;25(12):1858-65. doi: 10.1016/j.jvir.2014.08.019. Epub 2014 Oct 11.
4
Risk factors and clinical course of portal and/or splenic vein thrombosis after partial splenic embolization.部分脾栓塞术后门静脉和/或脾静脉血栓形成的危险因素及临床病程
Acta Radiol. 2009 Jul;50(6):617-23. doi: 10.1080/02841850902922779.
5
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成伴静脉曲张出血:一项前瞻性队列研究的结果及预测因素
Liver Int. 2016 May;36(5):667-76. doi: 10.1111/liv.12929. Epub 2015 Aug 28.
6
Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.肝硬化和非肝硬化肝脏患者急性和慢性门静脉血栓形成的血管内治疗
Acta Radiol. 2016 May;57(5):572-9. doi: 10.1177/0284185115595060. Epub 2015 Aug 7.
7
Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.经颈静脉肝内门体分流术与内镜治疗加抗凝治疗肝硬化食管胃静脉曲张出血并门静脉血栓形成的比较。
Scand J Gastroenterol. 2022 Dec;57(12):1494-1502. doi: 10.1080/00365521.2022.2094724. Epub 2022 Jul 8.
8
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.肝硬化合并门静脉血栓形成患者抗凝治疗的效果:系统评价和荟萃分析。
Gastroenterology. 2017 Aug;153(2):480-487.e1. doi: 10.1053/j.gastro.2017.04.042. Epub 2017 May 4.
9
Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis.肝硬化合并门静脉血栓形成患者经颈静脉肝内门体分流术(TIPS)与内镜下硬化剂注射治疗(EBL)的临床疗效比较
Abdom Imaging. 2015 Aug;40(6):1813-20. doi: 10.1007/s00261-014-0320-9.
10
Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.肝硬化患者非恶性门静脉血栓形成的抗凝疗效与安全性
Gastroenterol Hepatol. 2018 Dec;41(10):611-617. doi: 10.1016/j.gastrohep.2018.06.005. Epub 2018 Jul 24.

引用本文的文献

1
Efficacy and Safety of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies.抗凝剂在肝硬化合并门静脉血栓形成患者中的疗效和安全性:一项对随机和非随机研究的系统评价与荟萃分析
JGH Open. 2025 Aug 8;9(8):e70194. doi: 10.1002/jgh3.70194. eCollection 2025 Aug.
2
Portal venous blood flow velocity is a factor associated with portal venous thrombosis after partial splenic artery embolization in hepatic cirrhosis patients.门静脉血流速度是肝硬化患者部分脾动脉栓塞术后门静脉血栓形成的相关因素。
Ann Med Surg (Lond). 2023 Dec 11;86(2):650-654. doi: 10.1097/MS9.0000000000001577. eCollection 2024 Feb.
3
Anticoagulation for the Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis of Comparative Studies.
肝硬化门静脉血栓形成治疗的抗凝治疗:比较研究的系统评价和荟萃分析
J Clin Exp Hepatol. 2023 May-Jun;13(3):404-413. doi: 10.1016/j.jceh.2022.12.016. Epub 2023 Jan 3.
4
Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients.低分子肝素治疗肝硬化门静脉血栓形成的评价。
Medicina (Kaunas). 2023 Feb 4;59(2):292. doi: 10.3390/medicina59020292.
5
The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis.抗凝剂治疗肝硬化门静脉血栓形成的疗效和安全性:系统评价和荟萃分析。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221104797. doi: 10.1177/10760296221104797.
6
<Editors' Choice> Long-term outcomes of the partial splenectomy for hypersplenism after portoenterostomy of patients with biliary atresia.<编辑推荐> 胆肠吻合术后部分脾切除术治疗胆道闭锁患者脾功能亢进的长期疗效。
Nagoya J Med Sci. 2021 Nov;83(4):765-771. doi: 10.18999/nagjms.83.4.765.
7
Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study.经颈静脉肝内门体分流术治疗合并或不合并门静脉血栓形成的肝硬化的比较:一项回顾性研究
Front Med (Lausanne). 2021 Oct 4;8:737984. doi: 10.3389/fmed.2021.737984. eCollection 2021.
8
Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis.肝硬化患者抗凝治疗的安全性和疗效:一项荟萃分析。
Can J Gastroenterol Hepatol. 2021 Apr 21;2021:8859602. doi: 10.1155/2021/8859602. eCollection 2021.
9
Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis.肝硬化患者脾切除或脾动脉栓塞术后发生肠系膜静脉血栓形成:系统评价和荟萃分析。
Adv Ther. 2021 Apr;38(4):1904-1930. doi: 10.1007/s12325-021-01652-7. Epub 2021 Mar 9.
10
Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai).肝硬化门静脉血栓形成管理共识(2020 上海)。
J Dig Dis. 2021 Apr;22(4):176-186. doi: 10.1111/1751-2980.12970. Epub 2021 Mar 7.